At the end of 2021, Dr. Alexandre García Escrivá (Chief Physician Hospital Denia and Head of the Neurology Department of Policlinica Glorieta) and his team gave a lecture on memory impairment and dementia at the Euro Club Denia.
It was also about knowing the demarcation between the two. In contrast to normal memory impairment, dementia is characterized by persistent limitations in intellectual functioning that interfere with an individual’s daily life. Deficits/abnormalities in the following areas are characteristic:
- Abstract Thinking
- Abstract judging
- Language, memory, reasoning
- constructive tasks
- Recognition of the perceived
- personality changes
Dementia is a generic term for all diseases that have in common the permanent loss of higher abilities and the change in the patient’s behavior.
Given the assumption that a patient suffers from dementia, it is given the following name: Alzheimer’s disease, dementia due to Lewy – body, vascular dementia and the like.
If we add the term “senile,” it refers to the age at which symptoms first appear. Presenile appears before the age of 65, senile, the symptoms only appear after this age. This term is usually no longer used because it has negative connotations.
“We are all forgetful! But when is this forgetfulness alarming? If they interfere with normal functioning and work performance inside or outside the home!”
– dr Alexandre García Escrivá (Hospital Denia and Head of the Neurology Department of the Policlinica Glorieta)
Although there is no cure for dementia, there are numerous drug therapies available today. But even without medication, a lot can be achieved. Thus, cognitive stimulation is understood to mean the set of techniques aimed at improving the cognitive functions that every human being has.
In autoimmune encephalitis (AE), the less altered areas are strengthened to keep them performing as long as possible. It has been shown that all patients who participate in cognitive skills training improve their quality of life and mood, and slow down the course of disease deterioration in early and middle stages.
